Tarsus Pharmaceuticals, Inc.

Direct answer

Tarsus Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker TARS.

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is...

Can you invest in Tarsus Pharmaceuticals, Inc.?

Yes. Tarsus Pharmaceuticals, Inc. trades publicly on NASDAQ as TARS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Tarsus Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.